Oncolytic Virus Therapy Market Size And Share

  • Report Code : TIPRE00014846
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Marktgröße für onkolytische Virustherapie, Anteilsanalyse bis 2025-2031

Buy Now

Oncolytic Virus Therapy Market Report Oncolytic Virus Therapy Market Scope and Analysis Oncolytic Virus Therapy Market Size and Share

Oncolytic Virus Therapy Market Report Analysis

Oncolytic Virus Therapy Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Amgen Inc
  • Oncolytics Biotech, Inc.
  • Merck & Co., Inc.
  • Transgene
  • Oncolys BioPharma Inc.
  • Targovax ASA
  • Vyriad Inc.
  • Genelux Corporation
  • Sorrento Therapeutics, Inc.

Regional Overview

  • Nordamerika
  • Europa
  • Asien-Pazifik
  • Süd- und Mittelamerika
  • Mittlerer Osten und Afrika

Market Segmentation

By Produkttyp
  • Vaccinia-Virus-basierte onkolytische Viren
  • HSV-basierte onkolytische Viren
  • Adenoviren-basierte onkolytische Viren
  • Newcastle-Disease-Virus-basierte onkolytische Viren
  • Vesikuläre Stomatitis-Virus-basierte onkolytische Viren
By Anwendung
  • Brustkrebs
  • Lungenkrebs
  • Prostatakrebs
  • Melanom
  • Hirntumor
  • Blutkrebs
By Endbenutzer
  • Krankenhäuser
  • Spezialkliniken
  • Krebsforschungsinstitute
By Geographie
  • Nordamerika
  • Europa
  • Asien-Pazifik
  • Süd- und Mittelamerika